Lung transplantation and survival in children with cystic fibrosis: Solid statistics - Flawed interpretation

Authors: Sweet, Stuart C.1; Aurora, Paul2; Benden, Christian3; Wong, Jackson Y.4; Goldfarb, Samuel B.5; Elidemir, Okan6; Woo, Marlyn S.7; Mallory, George B.6

Source: Pediatric Transplantation, Volume 12, Number 2, March 2008 , pp. 129-136(8)

Publisher: Wiley-Blackwell

Buy & download fulltext article:

OR

Price: $48.00 plus tax (Refund Policy)

Abstract:

Sweet SC, Aurora P, Benden C, Wong JY, Goldfarb SB, Elidemir O, Woo MS, Mallory Jr. GB, on behalf of the International Pediatric Lung Transplant Collaborative. Lung transplantation and survival in children with cystic fibrosis: Solid statistics - Flawed interpretation.

Pediatr Transplantation 2008: 12: 129-136. © 2008 Blackwell Munksgaard Abstract: 

In their provocative paper, “Lung transplantation and survival in children with cystic fibrosis,” Liou and colleagues state that “Prolongation of life by means of lung transplantation should not be expected in children with cystic fibrosis. A prospective, randomized trial is needed to clarify whether and when patients derive a survival and quality of life benefit from lung transplantation.” Unfortunately, that conclusion is not supportable. Liou's dataset introduced bias against transplantation by using covariates obtained well before the time of transplant (when predicted survival was good) and having a cohort with lower than expected post-transplant survival than reported elsewhere. The calculated hazard ratios are based on factors that may have changed between listing and transplant, and do not reflect true benefit on a patient by patient basis. The findings of the study are contrary to other studies using similar methods. Finally, recent changes in US lung transplant allocation policy may have made the study findings moot. In contrast to Liou's suggestion to perform an ethically and logistically challenging randomized trial to verify the benefit of lung transplantation, a research agenda is recommended for pediatric lung transplantation for cystic fibrosis that focuses on developing strategies to continually reassess and maximize quality of life and survival benefit.

Keywords: lung transplantation; cystic fibrosis; survival analysis; quality of life

Document Type: Commentary

DOI: http://dx.doi.org/10.1111/j.1399-3046.2008.00924.x

Affiliations: 1: Department of Pediatrics, Washington University, St. Louis, MO, USA 2: Department of Paediatric Respiratory Medicine, Great Ormond Street Hospital for Children, London, UK 3: Division of Pulmonary Medicine and Lung Transplantation, University Hospital, Zurich, Switzerland 4: Division of Pediatric Respiratory Medicine, University of Alberta, Edmonton, AB, Canada 5: Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA, USA 6: Pediatric Pulmonology, Baylor College of Medicine, Houston, TX, USA 7: Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, CA, USA

Publication date: 2008-03-01

Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page